What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?

OBJECTIVES: To examine incidence of treatment changes due to abnormal blood-test results and, to explore rates of treatment changes due to liver, kidney and haematological blood-test abnormalities in autoimmune rheumatic diseases (AIRD) treated with low-dose MTX or LEF. METHODS: Data for people with...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakafero, Georgina, Grainge, Matthew J, Card, Tim, Mallen, Christian D, Zhang, Weiya, Doherty, Michael, Taal, Maarten W, Aithal, Guruprasad P, Abhishek, Abhishek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645271/
https://www.ncbi.nlm.nih.gov/pubmed/33725120
http://dx.doi.org/10.1093/rheumatology/keab254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645271/
https://www.ncbi.nlm.nih.gov/pubmed/33725120
http://dx.doi.org/10.1093/rheumatology/keab254

Ejemplares similares